Cargando…

The Notch pathway in ovarian carcinomas and adenomas

Elements of the Notch pathway regulate differentiation; we investigated the expression of such elements in epithelial ovarian tumours. A total of 32 ovarian tumour samples (17 adenocarcinomas, three borderline tumours, 12 adenomas), two human ovarian cancer (A2780, OVCAR3), and one ovarian surface (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hopfer, O, Zwahlen, D, Fey, M F, Aebi, S
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2005
Materias:	Genetics and Genomics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361628/ https://www.ncbi.nlm.nih.gov/pubmed/16136053 http://dx.doi.org/10.1038/sj.bjc.6602719

Ejemplares similares

Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor
por: Galamb, O, et al.
Publicado: (2010)

Wnt signalling in adenomas of familial adenomatous polyposis patients
por: Caldwell, G M, et al.
Publicado: (2010)

A seven-gene prognostic model for platinum-treated ovarian carcinomas
por: Sabatier, R, et al.
Publicado: (2011)

The Wnt antagonist sFRP1 is downregulated in premalignant large bowel adenomas
por: Caldwell, G M, et al.
Publicado: (2006)

Thymidylate synthase polymorphisms, folate and B-vitamin intake, and risk of colorectal adenoma
por: Hubner, R A, et al.
Publicado: (2007)

Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma
por: Ali, I U, et al.
Publicado: (2005)

Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma
por: Schernhammer, E S, et al.
Publicado: (2006)

Inflammation-associated gene expression is altered between normal human ovarian surface epithelial cells and cell lines derived from ovarian adenocarcinomas
por: Gubbay, O, et al.
Publicado: (2005)

DNA copy number profiling reveals extensive genomic loss in hereditary BRCA1 and BRCA2 ovarian carcinomas
por: Kamieniak, M M, et al.
Publicado: (2013)

Gene expression profiling of human ovarian tumours
por: Biade, S, et al.
Publicado: (2006)

The BOADICEA model of genetic susceptibility to breast and ovarian cancer
por: Antoniou, A C, et al.
Publicado: (2004)

The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions
por: Antoniou, A C, et al.
Publicado: (2008)

Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium
por: Pearce, C L, et al.
Publicado: (2009)

MicroRNA deregulation and pathway alterations in nasopharyngeal carcinoma
por: Chen, H-C, et al.
Publicado: (2009)

Whole-genome sequencing revealed novel prognostic biomarkers and promising targets for therapy of ovarian clear cell carcinoma
por: Itamochi, Hiroaki, et al.
Publicado: (2017)

MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression
por: Diosdado, B, et al.
Publicado: (2009)

Expression of eEF1A2 is associated with clear cell histology in ovarian carcinomas: overexpression of the gene is not dependent on modifications at the EEF1A2 locus
por: Tomlinson, V A L, et al.
Publicado: (2007)

Identification of genes associated with platinum drug sensitivity and resistance in human ovarian cancer cells
por: Roberts, D, et al.
Publicado: (2005)

Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer
por: Quaye, L, et al.
Publicado: (2009)

Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis
por: Cunningham, J M, et al.
Publicado: (2009)

B-RAF mutation and accumulated gene methylation in aberrant crypt foci (ACF), sessile serrated adenoma/polyp (SSA/P) and cancer in SSA/P
por: Inoue, A, et al.
Publicado: (2015)

Methylation status of oestrogen receptor-α gene promoter sequences in human ovarian epithelial cell lines
por: O'Doherty, A M, et al.
Publicado: (2002)

Promoter hypermethylation of FANCF and outcome in advanced ovarian cancer
por: Lim, S L, et al.
Publicado: (2008)

Transcription factors and molecular epigenetic marks underlying EpCAM overexpression in ovarian cancer
por: van der Gun, B T F, et al.
Publicado: (2011)

Chemotherapy-induced dynamic gene expression changes in vivo are prognostic in ovarian cancer
por: Koussounadis, A, et al.
Publicado: (2014)

The E-cadherin repressor Snail is associated with lower overall survival of ovarian cancer patients
por: Blechschmidt, K, et al.
Publicado: (2008)

Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer
por: Abkevich, V, et al.
Publicado: (2012)

Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects
por: Shan, S J C, et al.
Publicado: (2007)

Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer
por: Pal, T, et al.
Publicado: (2012)

Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines
por: Terasawa, K, et al.
Publicado: (2006)

Chromosomal imbalances associated with anaplastic transformation of follicular thyroid carcinomas
por: Rodrigues, R F, et al.
Publicado: (2004)

Mutation analysis of the EGFR gene and downstream signalling pathway in histologic samples of malignant pleural mesothelioma
por: Mezzapelle, R, et al.
Publicado: (2013)

Coexpression of EphB4 and ephrinB2 in tumour advancement of ovarian cancers
por: Alam, S M, et al.
Publicado: (2008)

Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study
por: Jakubowska, A, et al.
Publicado: (2012)

Oral contraceptive and reproductive risk factors for ovarian cancer within sisters in the breast cancer family registry
por: Ferris, J S, et al.
Publicado: (2014)

Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci
por: Kar, Siddhartha P, et al.
Publicado: (2017)

SLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinoma
por: Astuti, D, et al.
Publicado: (2004)

Reorganisation of Wnt-response pathways in colorectal tumorigenesis
por: Caldwell, G M, et al.
Publicado: (2008)

Overexpression of aurora B kinase (AURKB) in primary non-small cell lung carcinoma is frequent, generally driven from one allele, and correlates with the level of genetic instability
por: Smith, S L, et al.
Publicado: (2005)

Wilms' tumour 1 can suppress hTERT gene expression and telomerase activity in clear cell renal cell carcinoma via multiple pathways
por: Sitaram, R T, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_d8hjbjkl14go2181asqq5a78hn